Author: amjadalipk

Study Finds Herbal Formulation Ṭila-i Muhāsā Effective for Acne

Topical use of the herbal formulation Ṭila-i Muhāsā (TM) was found to be effective and well-tolerated for patients with moderate to severe acne vulgaris, according to study findings published in the Journal of Herbal Medicine. The single-arm, interventional study included patients who were clinically diagnosed with facial acne vulgaris from Karnataka, India, from March 2019 […]

Determining Whether Adding RP1 to Cemiplimab Helps CSCC Patients

A presentation at the American Society of Clinical Oncology (ASCO) 2022 Annual meeting, which was held 3-7 June 2022, in Chicago, IL, described the CERPASS trial in progress (NCT04050436). CERPASS is testing whether adding an enhanced potency oncolytic herpes simplex virus 1 (HSV-1) that expresses a fusogenic glycoprotein and granulocyte macrophage colony stimulating factor (collectively […]

Progression From Asymptomatic to Symptomatic Gallstones: The Risk Factors

Approximately 22% of patients with asymptomatic gallstones became symptomatic after 10 years with 25% of these patients needing interventional procedures. Moreover, several risk factors, like obesity, predicted disease progression. These are the findings of a study published in Clinical Gastroenterology and Hepatology. Asymptomatic gallstones are common yet there is limited knowledge on how they develop. […]

Endocrine Society, June 11-14 – Physician’s Weekly

The annual meeting of the Endocrine Society was held from June 11 to 14 in Atlanta and attracted approximately 7,000 participants from around the world, including clinicians, academicians, allied health professionals, and others interested in endocrine and metabolic disorders. The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, growth […]

Lisocabtagene maraleucel improves survival for relapsed or refractory large B-cell lymphoma

1. Median event-free survival in the liso-cel group was significantly greater than in the standard-of-care group (10.1 months vs. 2.3 months). 2. Grade 3 or worse neutropenia was more common among the liso-cel group than control. Evidence Rating Level: 1 (Excellent) Study Rundown: Primary refractory large B-cell lymphoma (LBCL) refers to disease relapse within 12 […]

Extramedullary vs. Intramedullary Implants

Although intramedullary implants are frequently used to treat stable intertrochanteric (IT) fractures, there was little data to show that they are preferable to extramedullary implants in treating these fractures. For a study, researchers sought to assess intramedullary vs. extramedullary implants’ short-term (30-day) results in patients with closed nondisplaced stable IT fractures. Between 2016 and 2019, […]

Position Paper Backs Bronchial Allergen Challenge Use

Although bronchial allergen challenge (BAC) is occasionally used to distinguish patients with allergic asthma among those with atopic asthma, it is currently considered a research tool without any protocols for use beyond diagnosing mild asthma and fulfilling study needs, according to Ioana Agache, MD, and colleagues.   Expanding Bronchial Allergen Challenge Application A European Academy […]

Back To Top